Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-11-05
1977-05-03
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424344, A61K 3120
Patent
active
040215733
ABSTRACT:
Skin diseases resulting from abnormal metabolic processes, such as acne and psoriasis, are treated on a repetitive basis, either internally or topically, with a dermatologically sufficient amount of 11-(2',6',6'-trimethylcyclohex-1'-enyl-1')-5,9-dimethylundeca-2,4,6,8,10-p entenoic acid or its physiologically acceptable salts to reduce the inflammation. The subject acid or its salts are found to provide remission of the dermatologically diseased condition, while avoiding side effects concommitant with the use of other analgous compounds.
REFERENCES:
patent: 3006939 (1961-10-01), Pommer et al.
patent: 3689667 (1972-09-01), Lee
patent: 3729568 (1973-04-01), Kligman
patent: 3882244 (1975-05-01), Lee
Stedman's Medical Dictionary, 21st Edition, (1966), pp. 784-785, 1320.
Frost et al., JAMA, March 10, 1969, vol. 207, No. 10, pp. 1863-1868.
Goldsmith et al., Medical Intelligence, vol. 286, No. 15, 4/13/72, pp. 821-823.
Orfanos et al., British J. of Dermatology, (1973), 88, 167, pp. 167-182.
Drezin Norman A.
The Regents of the University of California
LandOfFree
Psoriasis treatment with retinoic acid analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psoriasis treatment with retinoic acid analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psoriasis treatment with retinoic acid analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-346291